c Two hybrid bacteriocins, enterocin E50-52/pediocin PA-1 (EP) and pediocin PA-1/enterocin E50-52 (PE), were designed by combining the N terminus of enterocin E50-52 and the C terminus of pediocin PA-1 and by combining the C terminus of pediocin PA-1 and the N terminus of enterocin E50-52, respectively. Both hybrid bacteriocins showed reduced MICs compared to those of their natural counterparts. The MICs of hybrid PE and EP were 64-and 32-fold lower, respectively, than the MIC of pediocin PA-1 and 8-and 4-fold lower, respectively, than the MIC of enterocin E50-52. In this study, the effect of hybrid as well as wildtype (WT) bacteriocins on the transmembrane electrical potential (⌬⌿) and their ability to induce the efflux of intracellular ATP were investigated. Enterocin E50-52, pediocin PA-1, and hybrid bacteriocin PE were able to dissipate ⌬⌿, but EP was unable to deplete this component. Both hybrid bacteriocins caused a loss of the intracellular concentration of ATP. EP, however, caused a faster efflux than PE and enterocin E50-52. Enterocin E50-52 and hybrids PE and EP were active against the Gram-positive and Gram-negative bacteria tested, such as Micrococcus luteus, Salmonella enterica serovar Enteritidis 20E1090, and Escherichia coli O157:H7. The hybrid bacteriocins designed and described herein are antimicrobial peptides with MICs lower those of their natural counterparts. Both hybrid peptides induce the loss of intracellular ATP and are capable of inhibiting Gram-negative bacteria, and PE dissipates the electrical potential. In this study, the MIC of hybrid bacteriocin PE decreased 64-fold compared to the MIC of its natural peptide counterpart, pediocin PA-1. Inhibition of Gram-negative pathogens confers an additional advantage for the application of these peptides in therapeutics.
B
acteriocins are membrane-permeating, mostly cationic, ribosomally synthesized antimicrobial peptides (AMPs) produced by bacteria (1) . These peptides are synthesized together with cognate immunity proteins in order to render the bacteriocin-producing bacteria resistant to their own bacteriocins (2) (3) (4) . Bacteriocins produced by lactic acid bacteria (LAB) have been extensively studied by the use of genetic modification and protein engineering due to their potential application as nontoxic food preservatives and therapeutic agents (5) . The LAB bacteriocins nisin and pediocin PA-1 are frequently studied and used as food biopreservatives (3, 6) . The potential of LAB bacteriocins in medical applications is exemplified by previously reported results which indicated that the oral intake of bacteriocin-producing LAB protects mice from lethal doses of Listeria monocytogenes (7) . Therefore, LAB bacteriocins are the logical alternative to clinical antibiotics (8) and/or may help to enhance the efficacy of current antibiotics (9, 10) .
All pediocin-like bacteriocins contain disulfide bridges and a common YGNG(V/L) motif (pediocin box) which forms an Sshaped, sheet-like structure followed by a hinge and a somewhat more hydrophobic and diverse helix-containing C-terminal half (11, 12) . The hinge enables the N-terminal sheet-like region and the C-terminal helix-containing region to move relative to one another and may allow the more hydrophobic C-terminal half to extend into the hydrophobic part of target cell membranes. This results in the cationic and rather hydrophilic N-terminal half remaining in the hydrophilic exterior (4, 13) .
It has been suggested that these antimicrobial peptides are active only against a limited number of bacteria belonging to closely related species or genera of the bacteriocin-producing organisms (14) . However, recent reports have indicated a broader range of inhibition (15) (16) (17) . Many species within the genus Enterococcus have been described to be capable of bacteriocin production (18, 19) . These bacteriocins are heterogeneous in structure and differ in their inhibition spectra. The enterococcal bacteriocins are diverse and may include the pediocin-like class IIa and the leaderless class IIc forms (20) .
The mode of action of this group of bacteriocins against Grampositive bacteria has been studied in-depth and is known to dissipate the membrane potential and pH gradient and induce the loss of intracellular ATP (21, 22) . However, the mechanism of action against Gram-negative bacteria is poorly understood. It has been proposed that the antibacterial target of these cationic peptides is the cytoplasmic membrane (23) . Cationic peptides are generally regarded to be capable of electrostatic interactions with the negatively charged head groups of bacterial phospholipids, followed by insertion into the membranes of planar bilayers or liposomes, forming transient channels (24) . Such channel formation leads to the leakage of cell contents and subsequent cell death. Wu et al. (12) adopted an assay involving the membrane potential-sensitive dye 3,3=-dipropylthiadicarbocyanine iodide [di-S-C3-(5)] in or-der to measure the disruption of the electrical potential gradient across the cytoplasmic membrane of intact bacteria using the Escherichia coli mutant DC2 with defective outer membranes, in order to perform this assay in the absence of EDTA (12) . Through either electron transport or ATP hydrolysis, bacteria eject protons and maintain a proton motive force comprised of an electrical potential (⌬⌿) gradient (oriented internal negative) and a pH gradient (⌬pH; oriented internal alkaline) (25) .
In this study, pediocin PA-1 and enterocin E50-52 were used in order to modify the peptide sequences. Both bacteriocins belong to the most-studied group of bacteriocins, class II. Enterocin E50-52 was available in our laboratories, and pediocin PA-1 was selected since it has been extensively studied. Both of these bacteriocins possess the distinguishing N-terminal YGNGV motif. The hinge region (between the N-terminal sheet-like structure and C-terminal helix-containing region) of these bacteriocins was identified for modification because it is responsible for flexibility. Such flexibility may enhance the overall affinity with target molecules of the cell membrane. For design, both bacteriocins were cut at this region and rejoined to form hybrid bacteriocins enterocin E50-52/pediocin PA-1 (EP) and pediocin PA-1/enterocin E50-52 (PE). The two hybrid bacteriocins consisted of the N terminus of enterocin E50-52 along with the C terminus of pediocin PA-1 and of the C terminus of pediocin PA-1 along with the N terminus of enterocin E50-52, respectively. In this way, the effect of the N terminus of one bacteriocin on the C terminus of the other in terms of the MIC, ATP depletion, and dissipation of the membrane potential in target bacteria was studied.
MATERIALS AND METHODS
Bacterial strains and media. Micrococcus luteus ATCC 10420 was from the Rutgers laboratory culture collection, and Salmonella enterica serovar Enteritidis 20E1090 and Escherichia coli O157:H7 were provided by K. R. Matthews (Rutgers State University). All target strains were grown in brain heart infusion (BHI) medium at 37°C for 14 to 16 h in order to obtain log-phase cells. All media and buffer components were purchased from Difco (BD Biosciences, San Jose, CA) and Sigma-Aldrich (St. Louis, MO).
Design and synthesis of hybrid bacteriocins. The hybrid bacteriocins PE and EP were designed by breaking the peptide bonds between the valine (V) and cysteine (C) in the hinge region of enterocin E50-52 and between the valine (V) and threonine (T) in the hinge region of pediocin PA-1. The N-terminal regions of both peptides were rejoined with the C-terminal parts of the opposite bacteriocin to design hybrid bacteriocins PE and EP, as shown in Table 1 . Both hybrid and wild-type (WT) bacteriocins were synthesized de novo at Temple University (Philadelphia, PA) using solid-phase peptide synthesis. The authenticity of the newly synthesized peptides was confirmed through amino acid sequencing. Earlier, this method was extensively used to synthesize different bacteriocins (26, 27) .
Determination of MICs. The MIC values of both the synthetic and natural peptides against indicator strain M. luteus ATCC 10420 were determined using a 96-well microplate assay (28, 29) . The minimum amount of peptide that resulted in no increase in turbidity when the optical density at 595 nm (OD 595 ) was measured (turbidity value, Յ0.1) was considered no growth. In brief, serial 2-fold dilutions of each peptide were made in double-distilled sterile water with a total volume of 100 l, the diluted peptide was mixed with 100 l of the indicator strain (OD 595 , 0.1) in 2ϫ BHI medium, and the mixture was incubated at 30°C for 18 h. The sample with no additional bacteriocin was considered the control. The assay was performed with 3 samples per batch. Results were considered significant when P was Ͻ0.05.
Time-kill kinetics. M. luteus ATCC 10420, S. Enteritidis 20E1090, and E. coli O157:H7 were selected as target bacteria. The assay was performed in 96-well microplates. Each well was filled with 100 l of bacteriocin at the MIC and 100 l of cells at an OD 595 of 0.1 in 2ϫ BHI medium. These samples were incubated at 30°C in a microplate reader (ThermoMax; Molecular Devices, Sunnyvale, CA), and the OD 595 was monitored at 2-h intervals for 14 h.
ATP depletion assay. The effect of the hybrid and wild-type bacteriocins on the intracellular ATP content of the targeted bacteria was determined as described by Murdock et al. (30) . Briefly, target cells were grown to mid-log phase in the respective media and collected by centrifugation at 3,500 ϫ g for 10 min at 4°C (Hermle-Labortechnik, Wehingen, Germany). The pellet was resuspended and washed twice in equal volumes of 50 mM HEPES buffer, pH 6.5 (Fisher Scientific, Pittsburgh, PA). For the purpose of energization, the cells were resuspended in one-half of their original volume in 50 mM HEPES buffer (pH 6.5) containing 0.2% glucose and incubated at room temperature for 20 min prior to use in timedependent assays. ATP measurements were taken using a commercially available ATP bioluminescent assay kit (Sigma, St. Louis, MO). To determine the extracellular levels of ATP, 100 l of the cell suspension was diluted 1:50 in fresh buffer and combined with an equal portion of the ATP assay mix. The assay was performed according to the manufacturer's guidelines. Light emission was detected using a spectrophotometer (Luminoskan TL Plus luminometer; Labsystems Oy, Helsinki, Finland). To determine the total (intracellular and extracellular) levels of ATP, 20 l of the cell suspension was mixed with 80 l of dimethyl sulfoxide (DMSO) for 5 min at room temperature to permeabilize the cells. Equal portions of the permeabilized cell suspension and the ATP assay mix were combined. The concentration of intracellular ATP was determined by calculating the difference in the total and extracellular ATP concentrations.
Membrane potential dissipation assay. The effect of synthetic and wild-type bacteriocins on the transmembrane electrical potential (⌬⌿) of sensitive cells was determined by using the following method. Target bacteria were grown to mid-log phase in 50 ml of the respective media and collected through centrifugation (3,000 ϫ g, 10 min at 4°C). The pellet was washed twice in equal volumes of 50 mM potassium HEPES Fig. 1 . The MIC of hybrid PE was 8.01-fold lower than that of wild-type E50-52 and 64.1-fold lower than that of pediocin PA-1 (P Ͻ 0.05). Hybrid PE was more potent than hybrid EP, as the MIC was two times lower.
(K-HEPES) buffer, pH 7.0 (Fisher Scientific), resuspended in 1/100 (by volume) of the original K-HEPES buffer, and retained on ice prior to use. The fluorescent probe 3,3=-dipropylthiadicarbocyanine iodide [di-S-C3-(5)] was used to monitor changes in ⌬⌿. The fluorescence measurements (LS50B fluorescence spectrometer; PerkinElmer, Fremont, CA) were initiated, followed by the addition of 5 l of di-S-C3-(5) and 10 l of the cell concentrate in buffer with quick mixing. After the stabilization of the fluorescence signal, 10 l nigericin (MP Biomedicals, Solon, OH) from a 5 mM stock (final concentration, 12.5 M) in 95% ethanol with 1 mM K-EDTA was added. Subsequently, either buffer with 1 mM K-EDTA or bacteriocin in buffer with 1 mM K-EDTA was added to cells loaded with the probe. In all assays, 10 l valinomycin (MP Biomedicals, Santa Ana, CA) from a 2 mM stock (final concentration, 10 M) in 95% ethanol with 1 mM K-EDTA was added to collapse any remaining residual ⌬⌿. A PerkinElmer LS50B fluorescence spectrometer with excitation and emission wavelengths of 643 and 666 nm, respectively, a 10-nm slit width, and a 1,800-s assay duration with reading every 0.1 s was used for all assays. Statistical analysis. Experiments were performed in triplicate, and mean values along with the standard errors of the means (SEMs) were plotted. Three independent experiments were performed to monitor the reproducibility of the results. The level of statistical significance was analyzed as a P value of Ͻ0.05.
RESULTS
MICs of wild-type and hybrid bacteriocins. MICs were used in order to measure the efficacy of the hybrid and wild-type bacteriocins against the M. luteus indicator strain. The MIC values (the concentrations of bacteriocin at which the growth of the indicator strain was an OD 595 of 0.1 or less) were calculated from growth/sensitivity experiments (Fig. 1A to D) . MIC values of WT enterocin E50-52 and pediocin PA-1 were 12.5 M (OD 595 , 0.071) and 100 M (OD 595 , 0.077), respectively. The hybrid bacteriocins PE and EP had MICs of 1.56 M (OD 595 , 0.081) and 3.12 M (OD 595 , 0.054), respectively. While the MIC of WT enterocin E50-52 was found to be 8-fold lower than that of pediocin PA-1, the hybrid bacteriocin PE showed a MIC 64-fold lower than that of pediocin PA-1 and a MIC 8.01-fold lower (P Ͻ 0.05) than that of enterocin E50-52. Similarly, hybrid EP showed a MIC 32-fold lower than that of pediocin PA-1 and a MIC 4-fold lower than that of enterocin E50-52. For the hybrid peptides, the MIC of PE was 2-fold lower than that of EP (Table 1) .
Time-kill kinetics. Target bacteria were exposed to enterocin E50-52, pediocin PA-1, and their hybrid analogues, PE and EP (Fig. 2) . All bacteriocins tested were inhibitory to the target microorganisms, except for pediocin PA-1, which did not inhibit Gram-negative bacteria. Fig. 2A to C) .
Measurement of internal ATP concentration.
There was a loss of the internal ATP concentration of each tested strain when treated with enterocin E50-52 or one of the hybrid peptides (Fig.  3A to C) . To evaluate the efficacies of the hybrid bacteriocins in comparison with those of the wild-type molecules, the intracellular ATP concentration was determined at different time intervals. The maximum loss of ATP in M. luteus and E. coli was caused by hybrid EP. PE and enterocin E50-52 were identified to be the least effective. The loss of internal ATP caused by hybrid bacteriocin EP was somewhat higher than that caused by its WT counterpart, E50-52. In S. Enteritidis, the effects of both hybrids were nearly similar; they caused an increased loss of ATP compared to that caused by enterocin E50-52. The loss of internal ATP was observed in M. luteus treated with WT pediocin PA-1, whereas pediocin PA-1 had no significant effect on the internal ATP concentration of S. Enteritidis and E. coli cells.
Dissipation of membrane potential. The change in the transmembrane electrical potential (⌬⌿) was monitored by treating M. luteus cells with of all four bacteriocins (the WT and hybrid bacteriocins) at their MICs. The addition of enterocin E50-52, pediocin PA-1, and hybrid PE at their MICs completely dissipated the ⌬⌿ in M. luteus cells. Hybrid EP was unable to dissipate the ⌬⌿ when used at its MIC (Fig. 4) . The present study showed that the hybrid bacteriocin PE is a more potent antimicrobial peptide due to its ability to dissipate the ⌬⌿, than EP, which was also indicated by the lower MIC of PE. The N-terminal 2 amino acids (K and Y) and the C terminus of enterocin E50-52 seem to be responsible for the higher antimicrobial activity and dissipation of the membrane potential, as both wild-type enterocin E50-52 and PE contain this region (Table 1) .
To compare the dissipation of ⌬⌿ in Gram-positive and Gramnegative bacteria, the effect of enterocin E50-52 on E. coli cells was monitored. As described above, when M. luteus cells were treated with enterocin E50-52, there was a complete dissipation of ⌬⌿ (Fig. 4) . However, in the enterocin E50-52-treated E. coli cells, there was no change in ⌬⌿ (Fig. 5) . This could be due to the presence of an outer membrane which may inhibit the entry of the probe, which would prevent chelation (30) . Still, when these cells were treated with lysozyme and EDTA, the probe was able to enter and chelate; hence, a drop in the fluorescence was recorded, as depicted in Fig. 5 . The cells treated with EDTA alone responded intermediately to the bacteriocin treatment. When enterocin Closed circles, untreated control. Enterocin E50-52 caused rapid inhibition of the growth of all target cells used. Pediocin PA-1 was able to inhibit only M. luteus, whereas S. Enteritidis and E. coli cells were unaffected (P Ͼ 0.05). Hybrid PE caused more inhibition of growth of all the target bacteria than hybrid EP. The details of the domain swap are given in Table 1 . The experiments were done in triplicate, and mean values with SEMs are plotted. E50-52 was applied to the EDTA-lysozyme-treated cells, no effect on ⌬⌿ was detected, and therefore, this component was not affected by enterocin E50-52. A different mechanism of action could be involved in the inhibition of Gram-negative bacterial cells. As suggested by Messaoudi et al. (32) , Future research is necessary to investigate the mode of action of bacteriocins against Gram-negative bacteria.
DISCUSSION
Hybrid bacteriocins were designed from the sequences of two known bacteriocins, pediocin PA-1 and enterocin E50-52. These bacteriocins were considered templates for sequence modification, as they belong to one of the most studied groups of bacteriocins, the class II bacteriocins (33) . During the design of hybrid bacteriocins, modifications occurred by cutting and rejoining the N and C termini of both the wild-type bacteriocins at the hinge region. Afterwards, the effects of the N terminus of one bacteriocin on the C terminus of the other bacteriocin and vice versa were monitored. To evaluate the efficiencies of the hybrid bacteriocins, ATP efflux and dissipation of the membrane potential were monitored in Gram-positive and Gram-negative bacterial cells treated with PE and EP at their MICs.
In one of the hybrid bacteriocins, PE, the N-terminal region of enterocin E50-52 (TTKNYGNGV) was replaced by the N-terminal region of pediocin PA-1 (KYYGNGV). An 8-fold drop in the MIC of PE compared to the MIC of wild-type enterocin E50-52 and a more than 64-fold drop in the MIC of PE compared to the MIC of pediocin PA-1 were observed. The difference in the peptide sequence of wildtype enterocin E50-52 and the hybrid PE at the N-terminal region is only 4 amino acids (TTKN) in enterocin E50-52 and 2 amino acids (KY) in hybrid PE. The rest of the peptide sequence remained the same. The lengths of enterocin E50-52 and hybrid PE differed by only 2 amino acids: 39 and 37 residues, respectively. The net alteration was a reduction in the number of hydrophobic (T) residues, and therefore, an effective net positive charge (from a K residue) in the hybrid PE might account for the reduced MIC. The sequence and length of WT pediocin PA-1 and hybrid PE were highly variable, having 44 and 37 amino acid residues, respectively. The hybrid PE was found to be more potent than the hybrid EP (i.e., it had a 2-fold lower MIC). This indicated that at the N terminus there might be a specific ratio of enterocin E50-52, WT pediocin PA-1, and hybrid PE were able to completely dissipate the membrane potential in M. luteus, but hybrid EP was not. These experiments were performed three times, and the results were reproducible. au, arbitrary units.
hydrophobic and cationic residues for binding target molecules of the cell membrane that allows optimal bacteriocin activity. The cationic and hydrophobic amino acid residues present in class II bacteriocins play important roles in antimicrobial activity. Upon contact with target membranes, the cationic N terminus forms a half-beta-sheet-like structure that binds to the target cell surface, while the more hydrophobic helix-containing C-terminal half penetrates into the hydrophobic core of target cell membranes and binds to the mannose phosphotransferase permease, resulting in membrane leakage (34) . Similarly, Haugen et al. (11) performed peptide modifications and found that hybrid peptides are capable of inhibiting the activity of wild-type pediocin PA-1 through competitive binding, depicting a structure-function relationship.
Both wild-type pediocin PA-1 and wild-type enterocin E50-52 were able to inhibit the growing cells of M. luteus, but pediocin PA-1 was not able to inhibit S. Enteritidis or E. coli, whereas these strains were inhibited by enterocin E50-52. This finding is consistent with earlier data that pediocin PA-1 does not inhibit Gramnegative bacteria (31) . Hybrid PE was able to inhibit all the target strains tested, whereas EP was less effective. The trend of inhibition was found to be similar for enterocin E50-52 and EP, despite the target strain used: enterocin E50-52 was found to be the most effective against all strains, followed by EP. This suggests that the present approach of peptide modification might be helpful in enhancing the host range of bacteriocins, which are currently in high demand for use in both food biopreservation and therapeutics. Efforts have continuously been made in the recent past to improve the activity and host range of bacteriocins (34) . In this study, both hybrids and wild-type enterocin E50-52 were found to induce the loss of intracellular ATP within 5 min of treatment. The loss of intracellular ATP caused by EP was more pronounced than that caused by PE or E50-52 treatment. Pediocin PA-1 caused rapid efflux in M. luteus but was unable to do so in cells of S. Enteritidis and E. coli (P Ͼ 0.05), whereas enterocin E50-52 was able to cause a loss of internal ATP in all the target bacteria used. The loss of intracellular ATP could be due to efflux caused by pore formation, as the external ATP concentration was found to be inversely proportional to the internal ATP concentration. Other bacteriocins were previously demonstrated to cause a similar loss of internal ATP and to have a pore-forming nature (e.g., see reference 35).
Among hybrid bacteriocins, PE was shown to completely dissipate the membrane potential, while EP had no effect on the membrane potential. These two peptides differ in their amino acid sequences and lengths, suggesting that they have different modes of action and structure-function relationships. The wild-type bacteriocins E50-52 and PA-1 completely dissipated the membrane potential. Earlier studies also indicated that pediocin PA-1 completely dissipates the membrane potential (4). Such a dissipation of the membrane potential was not observed in E. coli cells treated with enterocin E50-52, but enterocin E50-52 caused a loss of internal ATP in the cells. This could be due to differences in the mode of action against Gram-positive and Gram-negative bacteria. Antimicrobial activity of enterocin E50-52 against different strains of Gramnegative bacteria has also been reported previously (32) . Our study indicates an opportunity for improved control of Gramnegative bacteria using more the potent hybrid analogues PE and EP. The hybrid bacteriocins designed and synthesized in the present study showed considerably decreased MICs compared to the MICs of their wild-type molecules. Further detailed studies are being planned in order to observe the mode of action of these bacteriocins on Gram-negative bacteria. Understanding the mode of action of these and other bacteriocins on Gram-negative bacteria is important, as it will lead to the broader use of bacteriocins and bacteriocin-derived molecules in both the food preservationand human health-related fields. and EDTA only showed a drop in fluorescence, whereas untreated cells did not respond. The treatment may facilitate the entry of probe and chelation, causing a drop in fluorescence, but there was no effect of treatment with WT E50-52 on the membrane potential of E. coli cells, suggesting a mode of action other than pore formation.
